Pharmacometrics 2020

Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development

(2010) Jeffrey D. Wetherington et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Antiviral Information Management System (AIMS): A Prototype for Operational Innovation in Drug Development

(2010) Pravin R. Jadhav et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry

(2010) Julie A. Stone et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Postexposure Inhalational Anthrax in Children

(2009) F. Li et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Quantitative Disease, Drug, and Trial Models

(2008) Jogarao V.S. Gobburu et al.   Annual Review of Pharmacology and Toxicology

Pharmacokinetic/Pharmacodynamic Modelling in??Diabetes Mellitus

(2008) Cornelia B Landersdorfer et al.   CLINICAL PHARMACOKINETICS

Leveraging Prior Quantitative Knowledge to Guide Drug Development Decisions and Regulatory Science Recommendations: Impact of FDA Pharmacometrics During 2004-2006

(2008) Yaning Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY